SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Merck
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
1580 80 0 MRK
Emcee:  Alfred W. Post Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1530Medical Journal Questions Efficacy of HPV Vaccine By JOHN CARREYROU and KEITH WDoc Bones-5/10/2007
1529More Questions on Cervical Cancer Vaccine Posted by Jacob Goldstein May 9, 200Doc Bones-5/10/2007
1528not that i know of. pre-existing conditions have always been excepted...strangemopgcw-5/10/2007
1527I don't understand that. The vaccine sounds exceptionally efficacious. No keokalani'nui-5/9/2007
1526Editorial Urges 'Cautious' Approach To Gardasil Cervical-Cancer Vaccine mopgcw-5/9/2007
1525FDA Rejects Merck's Request To Market Osteoarthritis Drug Associated Press Amopgcw-4/27/2007
1524Questions on Efficacy Cloud a Cancer Vaccine Merck Predicts Big Fall In Cervicalmopgcw-4/16/2007
1523FDA Panel's Vote Against Arcoxia Gives Merck New Headache in Painkiller Clasmopgcw-4/13/2007
1522Ruling in Texas Vioxx Case Could Be a Boon for Merck By HEATHER WON TESORIERO Apmopgcw-4/12/2007
1521Merck & Co.: NJ Supreme Ct Ruling Provides Promising Insights M 2007-04-05 0mopgcw-4/10/2007
1520Vioxx Successor Faces FDA Hurdles Merck Pushes Replacement For Disgraced Painkilmopgcw-4/4/2007
1519Court Favors Merck in Patent Fight By PETER LOFTUS March 29, 2007 5:11 p.m. A mopgcw-3/29/2007
1518Merck Cancels Work on a New Insomnia Medication [NYT] By STEPHANIE SAUL PublishDoc Bones-3/29/2007
1517Merck Wins First Midwest Case Over Former Painkiller Vioxx By HEATHER WON TESORImopgcw-3/27/2007
1516Forbes: Merck's March Madness David Kliff, Diabetic Investor 03.02.07, 1:15 mopgcw-3/9/2007
1515Merck & Co.: Surprising Mixed Verdict in First Phase MORGAN STA 2007-03-04 2mopgcw-3/8/2007
1514Merck Receives a Split Verdict From New Jersey Jury in Vioxx Trial By HEATHER Wmopgcw-3/4/2007
1513Merck Boosts Forecast, Aided by New-Drug Sales Delay at Rival Novartis May ProvDoc Bones-3/1/2007
1512Galvus Gets FDA Approvable Letter Mandating New Study: investorshub.comDewDiligence_on_SI-2/26/2007
1511Merck Ends Lobbying For Cervical-Cancer Vaccine By JOHN CARREYROU and SARAH RUBEmopgcw-2/21/2007
1510Merck to Pay $2.3 Billion in Tax Case By JESSE DRUCKER February 15, 2007; [WSJ]Doc Bones-2/15/2007
1509Here is the cdc website about hpv: cdc.gov Seems like every other day now I hekenhott-2/7/2007
1508I agree Merck, thru its lobbyist, are behaving in a totalitarian way. Kind of lCarey Thompson-2/7/2007
1507I am disappointed to see Merck pursue this, the firm used to be a great example mopgcw-2/7/2007
1506Merck's Net Income Skids 58%, Hurt by Patent Loss on Zocor [WSJ] Vaccine, ADoc Bones-1/30/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News